Last reviewed · How we verify
BAZEDOXIFENE ACETATE
BAZEDOXIFENE ACETATE is a drug. It is currently FDA-approved (first approved 2009).
At a glance
| Generic name | BAZEDOXIFENE ACETATE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 2009 |
Approved indications
Common side effects
Key clinical trials
- Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers (EARLY_PHASE1)
- Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens (PHASE2)
- Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis (PHASE2)
- Raising Insulin Sensitivity in Post Menopause (EARLY_PHASE1)
- The PROMISE Study: Duavee in Women With DCIS (PHASE2)
- Advancing Postmenopausal Preventive Therapy (PHASE2)
- Affect of Duavive on Mood & Anxiety Symptoms (PHASE1)
- Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BAZEDOXIFENE ACETATE CI brief — competitive landscape report
- BAZEDOXIFENE ACETATE updates RSS · CI watch RSS
Frequently asked questions about BAZEDOXIFENE ACETATE
What is BAZEDOXIFENE ACETATE?
BAZEDOXIFENE ACETATE is a Small molecule drug.
When was BAZEDOXIFENE ACETATE approved?
BAZEDOXIFENE ACETATE was first approved on 2009.
What development phase is BAZEDOXIFENE ACETATE in?
BAZEDOXIFENE ACETATE is FDA-approved (marketed).
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing